Published papers/reports and preprints
Refine by:
Type
Year
Ethnic disparities in COVID-19 mortality and cardiovascular disease in England and Wales between 2020-2022
Authors: Pineda-Moncusí M, Allery F, Abbasizanjani H, et al.
Nature Communications,
A population-based cross-sectional investigation of COVID-19 hospitalizations and mortality among autistic people
Authors: Nijhof D, Sosenko F, Mackay D, et al.
Journal of Autism and Developmental Disorders,
Replicating a COVID-19 study in a national England database to assess the generalisability of research with regional electronic health record data
Authors: Williams R, Jenkins D, Bolton T, et al.
BMJ Open,
Incidence and prevalence of asthma, chronic obstructive pulmonary disease and interstitial lung disease between 2004 and 2023: harmonised analyses of longitudinal cohorts across England, Wales, South-East Scotland and Northern Ireland
Authors: Whittaker H, Kramer Fiala Machado A, Hatam S, et al
Thorax,
Burden of cardiovascular diseases from 2020 to 2024: a national cohort in NHS England
Authors: Allara E, Shi W, Bolton T, et al
Preprints with The Lancet,
Impact of COVID-19 pandemic on rates of congenital heart disease procedures among children: prospective cohort analyses of 26 270 procedures in 17 860 children using CVD-COVID-UK consortium record linkage data
Authors: Suseeladevi AK, Denholm R, Babu-Narayan S, et al.
Open Heart,
Peripandemic outcomes of infants treated for sentinel congenital heart diseases in England and Wales
Authors: Huang Q, Lawlor D, Nolan J, et al.
Open Heart,
Hospital readmission after heart valve surgery in the United Kingdom
Authors: Chan J, Narayan P, Dong, T, et al.
JTCVS Open,
Prevalence and demographics of 331 rare diseases and associated COVID-19-related mortality among 58 million individuals: a nationwide retrospective observational study
Authors: Thygesen JH, Zhang H, Issa H, et al.
The Lancet Digital Health,
Use of sodium valproate and other antiseizure drug treatments in England and Wales: quantitative analysis of nationwide linked electronic health records
Authors: Dale C, Takhar R, Fan YY, et al
BMJ Medicine,
Surgical and transcatheter aortic valve interventions for aortic stenosis in England: sociodemographic variations in treatment trends and outcome over 20 years
Authors: Singh A, Chalmers F, Aslam S, et al
Heart,
Healthcare utilisation of 282,080 individuals with long COVID over two years: a multiple matched control, longitudinal cohort analysis
Authors: Mu Y, Dashtban A, Mizani MA, et al.
Journal of the Royal Society of Medicine,
Routine measurement of cardiometabolic disease risk factors in primary care in England before, during, and after the COVID-19 pandemic: A population-based cohort study
Authors: Ho, F, Dale, C, Mizani, M, et al
PLOS Medicine,
Risks of major arterial and venous thrombotic diseases after hospitalisation for influenza, pneumonia, and COVID-19: A population-wide cohort in 2.6 million people in Wales
Authors: Keene S, Abbasizanjani H, Torabi F, et al
Thrombosis Research,
Combinations of multiple long term conditions and risk of hospital admission or death during winter 2021-22 in England: population based cohort study
Authors: Islam, N, Shabnam, S, Khan, N, et al
BMJ Medicine,
Contemporary epidemiology of hospitalised heart failure with reduced versus preserved ejection fraction in England: a retrospective, cohort study of whole-population electronic health records
Authors: Fletcher R, Rockenschaub P, Neuen B, et al
The Lancet Public Health,
Association between ethnicity and emergency department visits in the last three months of life in England: a retrospective population-based study using electronic health records
Authors: Davies, J, Javiera, L, Chua, K.-C., et al
BMJ Public Health,
Trends in pediatric hospital admissions caused or contributed by SARS-CoV-2 infection in England
Authors: Wilde, H, Tomlinson, C, Mateen, B.A., et al
The Journal of Pediatrics,
The impact of COVID-19 vaccination on patients with congenital heart disease in England: a case-control study
Authors: Harrison C, Frain S, Jalalinajafabadi F, et al
Heart,
The impact of the COVID-19 pandemic on cardiovascular risk factors and events in England: a population-based cohort study
Authors: Bray B, O’Connell D, Robinson D, et al
Preprints with The Lancet,
COVID-19 diagnosis, vaccination during pregnancy, and adverse pregnancy outcomes of 865,654 women in England and Wales: a population-based cohort study.
Authors: Raffetti E, Bolton T, Nolan J et al.
The Lancet Regional Health - Europe,
The challenges of replication: a worked example of methods reproducibility using electronic health record data.
Authors: Williams R, Bolton T, Jenkins D et al.
medRxiv,
Cohort study of cardiovascular safety of different COVID-19 vaccination doses among 46 million adults in England.
Authors: Ip S, North T-L, Torabi F et al.
Nature Communications,
Vaccinations, cardiovascular drugs, hospitalisation and mortality in COVID-19 and Long COVID.
Authors: Dashtban A, Mizani MA, Pasea L et al.,
International Journal of Infectious Diseases.,
Risk of cardiovascular events following COVID-19 in people with and without pre-existing chronic respiratory disease.
Authors: Whittaker H, Kallis C, Bolton T et al
International Journal of Epidemiology,
A nationwide, population-based study on specialized care for acute heart failure throughout the COVID-19 pandemic.
Authors: Cannata A, Mizani MA, Bromage DI et al.,
European Journal of Heart Failure,
Ethnicity data resource in population-wide health records: completeness, coverage and granularity of diversity.
Authors: Pineda-Moncusí M, Allery F, Delmestri A et al.,
Scientific Data,
Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales.
Authors: The HDR UK COALESCE Consortium
The Lancet.,
Ensuring phenotyping algorithms using national electronic health records are FAIR: Meeting the needs of the cardiometabolic research community
Authors: BHF Data Science Centre
Zenodo,
Understanding covid-19 outcomes among people with intellectual disabilities in England.
Authors: Sosenko F, Mackay D, Pell JP et al.
BMC Public Health,
e-Consent in UK academic-led clinical trials: current practice, challenges and the need for more evidence.
Authors: Mitchell EJ, Appelbe D, Bravery A et al.
BioMed Central,
Sars-Cov-2 infection in people with Type 1 diabetes and hospital admission: an analysis of risk factors for England.
Authors: Heald AH , Jenkins DA, Williams R et al
Cardiovascular imaging research priorities.
Authors: MacArthur JAL, Yong GL, Dweck MR et al
Openheart,
Public survey to identify the most important areas for research into cardiovascular disease.
Authors: MacArthur, JAL, Khan, S, Blakelock, P et al
Zenodo,
Antipsychotic drug prescribing and mortality in people with dementia before and during the COVID-19 pandemic: a retrospective cohort study in Wales, UK.
Authors: Schnier C, McCarthy A, Morales DR et al
The Lancet Healthy Longevity,
Hospital admissions linked to SARS-CoV-2 infection in children and adolescents: cohort study of 3.2 million first ascertained infections in England.
Authors: Wilde H, Tomlinson C, Mateen BA et al
BMJ,
Use of NHS Digital datasets as trial data in the UK: a position paper.
Authors: Murray ML, Pinches H, Mafham M et al
Zenodo,
Charting a Course for Smartphones and Wearables to Transform Population Health Research.
Authors: Dixon WG, van der Veer SN, Mustafa Ali S et al
Journal of Medical Internet Research,
Harmonising electronic health records for reproducible research: challenges, solutions and recommendations from a UK-wide COVID-19 research collaboration.
Authors: Abbasizanjani H, Torabi F, Bedston S et al
BMC Medical Informatics and Decision Making,
The impact of the COVID-19 pandemic on cardiovascular disease prevention and management.
Authors: Dale CE, Takhar R, Carragher R et al
Nature Medicine,
Better End of Life 2022. Mind the gaps: understanding and improving out-of-hours care for people with advanced illness and their informal carers. Research report.
Authors: Pask, S, Davies JM, Mohamed A et al
Marie Curie,
Using national electronic health records for pandemic preparedness: validation of aparsimonious model for predicting excess deaths among those with COVID-19 – a datadriven retrospective cohort study.
Authors: Mizani MA, Dashtban A, Pasea L et al
Journal of the Royal Society of Medicine,
Effects of the COVID-19 pandemic on secondary care for cardiovascular disease in the UK: an electronic health record analysis across three countries.
Authors: Wright FL, Cheema K, Goldacre R et al
European Heart Journal,
Association of COVID-19 with major arterial and venous thrombotic diseases: apopulation-wide cohort study of 48 million adults in England and Wales.
Authors: Knight R, Walker V, Ip S et al
Circulation,
Data provenance and integrity of health-care systems data for clinical trials.
Authors: Murray ML, Love SB, Carpenter JR et al
The Lancet,
Association of severe mental illness with stroke outcomes and process-of-care quality indicators: nationwide cohort study.
Authors: Fleetwood K, Wild SH, Smith DJ et al
Cambridge University Press,
Workshop report – How can we use imaging data to better understand cardiovascular disease?
Authors: MacArthur J, Aronson HE, Bai W et al
Zenodo,
Standardizing reporting of brain and central nervous system tumors in the United Kingdom.
Authors: Poon MTC, Brennan PM, Jin K et al
Neuro-oncology,
COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records.
Authors: Thygesen JH, Tomlinson C, Hollings S et al
The Lancet,
A retrospective cohort study measured predicting and validating the impact of the COVID-19 pandemic in individuals with chronic kidney disease.
Authors: Dashtban A, Mizani MA, Denaxas S et al
Kidney International,
Indirect effects of the pandemic: highlighting the need for data-driven policy and preparedness.
Authors: Amitava Banerjee, Cathie Sudlow, and Mark Lawler
Sage Journals,
How to facilitate the use of healthcare systems data in cardiovascular clinical trials.
Authors: BHF Data Science Centre
Zenodo,
Risk of myocarditis and pericarditis following BNT162b2 and ChAdOx1 COVID-19 vaccinations.
Authors: Goddard K, Lewis N, Fireman B et al
medRxiv,
Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort.
Authors: Handy A, Banerjee A, Wood AM et al
Heart,
Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England.
Authors: Whiteley WN, Ip S, Cooper JA et al
PLOS Medicine.,
Workshop report – How can consumer wearables transform our understanding of cardiovascular disease.
Authors: British Heart Foundation Data Science Centre
Zenodo,
A nationwide deep learning pipeline to predict stroke and COVID-19 death in atrial fibrillation.
Authors: Handy A, Wood A, Sudlow C et al
medRxiv,
Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic.
Authors: Banerjee A, Chen S, Pasea L et al
European Journal of Preventive Cardiology,
Raised cardiovascular disease mortality after central nervous system tumour diagnosis: analysis of 171 926 patients from UK and USA.
Authors: Jin K, Brennan PM, Poon MTC et al
Society of NeuroOncology,
A strategy to reduce the carbon footprint of clinical trials.
Authors: Adsheada F, Al-Shahi Salmanb R, Aumonierc S et al
The Lancet,
Realising the full potential of data-enabled trials in the UK: a call for action.
Authors: Sydes MR, Barbachano Y, Bowman L et al
BMJ,
Accessing routinely collected health data to improve clinical trials: recent experience of access.
Authors: Macnair A, Love SB, Murray ML et al
Trials,
Linked electronic health records for research on a nationwide cohort of more than 54million people in England: data resource.
Authors: Wood A, Denholm R, Hollings S et al
BMJ,
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study.
Authors: Gupta R, Harrison EM, Ho A et al
The Lancet,
Monitoring indirect impact of COVID-19 pandemic on services for cardiovascular diseases in the UK.
Authors: Ball S, Banerjee A, Berry C et al
BMJ,
Testing for coronavirus (SARS-CoV-2) infection in populations with low infection prevalence: the largely ignored problem of false positives and the value of repeat testing.
Authors: Sudlow C, Diggle P, Warlow O et al
medRxiv,
Tracking Excess Deaths (TRACKED) – an interactive online tool to monitor excess deaths associated with the COVID-19 pandemic in the United Kingdom.
Authors: Poon MTC, Brennan PM, Jin K et al
Wellcome Open Res,
Distinguishing between direct and indirect consequences of covid-19.
Authors: Figueroa JD, Brennan PM, Theodoratou E et al
BMJ,
Using imaging to combat a pandemic: rationale for developing the UK National COVID-19 Chest Imaging Database.
Authors: Jacob J, Alexander D, Baillie JK et al
European Respiratory Journal,